Clinical Trial Update: Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating neratinib in combination with vinorelbine for breast cancer and advanced solid tumors has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• Vinorelbine (Vinorelbine)
• neratinib (neratinib)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Breast Cancer, Advanced Malignant Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-05-08